BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3258536)

  • 1. Discordant effect of interferon on natural killer activity and tumor cell sensitivity to lysis in hairy cell leukemia.
    Lahat N; Aghai E; Kotler A; Kinarty A; Sobel E; Gruener N; Froom P
    Blood; 1988 Apr; 71(4):1141-3. PubMed ID: 3258536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant effect of 2'-deoxycoformycin on natural killer cell activity and tumour cell sensitivity to lysis in hairy cell leukaemia--discordant effects of alpha interferon.
    Lahat N; Aghai E; Merchav S; Kinarty A; Sobel E; Froom P
    Scand J Immunol; 1990 Aug; 32(2):205-9. PubMed ID: 2389114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
    Griffiths SD; Cawley JC
    Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients.
    Liberati AM; De Angelis V; Fizzotti M; Schippa M; Cecchini M; Adiuto D; Di Clemente F; Palmisano L; Micozzi E; Zuccaccia M
    Cancer Immunol Immunother; 1994 May; 38(5):323-31. PubMed ID: 7512888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
    Reiter Z; Tomson S; Ozes ON; Taylor MW
    Blood; 1993 Apr; 81(7):1699-708. PubMed ID: 8096405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanism.
    Abrams SI; Brahmi Z
    Cell Immunol; 1986 Sep; 101(2):558-70. PubMed ID: 3489541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine and natural killing regulation of growth of a hairy cell leukemia-like cell line: the role of interferon-alpha and interleukin-2.
    Reiter Z; Ozes ON; Blatt LM; Taylor MW
    J Immunother (1991); 1992 Jan; 11(1):40-9. PubMed ID: 1734947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia.
    Bigda J; Mysliwska J; Dziadziuszko R; Bigda J; Mysliwski A; Hellmann A
    Leuk Lymphoma; 1993 May; 10(1-2):121-5. PubMed ID: 8104069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine-induced enhancement of the susceptibility of hairy cell leukaemia lymphocytes to natural killer cell lysis.
    Cordingley FT; Hoffbrand AV; Brenner MK
    Br J Haematol; 1988 Sep; 70(1):37-41. PubMed ID: 3140887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hairy cell leukemia cells are relatively NK-insensitive targets.
    Starling GC; Nimmo JC; Hart DN
    Pathology; 1988 Oct; 20(4):361-5. PubMed ID: 2977221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-interferon and lymphokine-activated killer cells in hairy cell leukemia.
    Griffiths SD; Cawley JC
    Leukemia; 1988 Jun; 2(6):377-81. PubMed ID: 3374170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events.
    Trentin L; Ambrosetti A; Zambello R; Agostini C; Masciarelli M; Vinante F; Chilosi M; Pizzolo G; Cetto G; Semenzato G
    Leuk Res; 1987; 11(9):843-7. PubMed ID: 3499539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
    Platsoucas CD
    Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR; Kamber M; Peck R
    Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and mechanism of IFN-gamma-induced protection of human tumor cells from lysis by lymphokine-activated killer cells.
    de Fries RU; Golub SH
    J Immunol; 1988 May; 140(10):3686-93. PubMed ID: 3129500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dual anti-tumor effect of a combination of interferon-alpha or interleukin-2 and 5-fluorouracil on natural killer (NK) cell-mediated cytotoxicity.
    Reiter Z; Ozes ON; Blatt LM; Taylor MW
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):103-11. PubMed ID: 1370257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
    Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
    Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia.
    Trentin L; Zambello R; Agostini C; Ambrosetti A; Chisesi T; Raimondi R; Bulian P; Pizzolo G; Semenzato G
    Blood; 1990 Apr; 75(7):1525-30. PubMed ID: 2317560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.